MUC1 and cancer: As a common explanation, immunity related to human mucin 1 could explain the risk for not only ovarian, breast, and endometrial cancers but also other MUC1-expressing cancers that have been targets of MUC1 vaccine trials (104), such as colorectal cancer and lung cancer, and point to the possible relevance of ovulatory cycles to their epidemiology.